InfuSystem Holdings (INFU) Total Current Liabilities (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Total Current Liabilities came in at $17.1 million in Q1 2026, up 7.35% YoY from $16.0 million in Q1 2025, and down 15.06% on a QoQ basis from $20.2 million in Q4 2025.
InfuSystem Holdings (INFU) Total Current Liabilities (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 17 years of Total Current Liabilities data on file, last reported at $17.1 million in Q1 2026.
- Quarterly Total Current Liabilities rose 7.35% year-over-year to $17.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.1 million (up 7.35% YoY) and the FY2025 annual result came in at $20.2 million, up 14.27% from the prior year.
- Total Current Liabilities declined to $17.1 million in Q1 2026, from $20.2 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $20.2 million in Q4 2025 to a low of $12.7 million in Q3 2022.
- A 5-year average of $15.8 million and a median of $15.9 million in 2025 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities retreated 12.09% — and 2024, when it gained 24.28%.
- Tracing INFU's Total Current Liabilities over 5 years: stood at $14.5 million in 2022, then increased by 8.61% to $15.7 million in 2023, then grew by 12.4% to $17.7 million in 2024, then grew by 14.27% to $20.2 million in 2025, then retreated by 15.06% to $17.1 million in 2026.
- The last three Total Current Liabilities figures came in at $17.1 million (Q1 2026), $20.2 million (Q4 2025), and $18.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.28 Bn |
| 10 | InfuSystem Holdings | 244.67 Mn | 243.70 Mn | 21.41 Mn | 15.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.30 Mn |
| Mar 31, 2026 | 17.14 Mn |
| Dec 31, 2025 | 20.18 Mn |
| Sep 30, 2025 | 18.72 Mn |
| Jun 30, 2025 | 15.86 Mn |
| Mar 31, 2025 | 15.97 Mn |
| Dec 31, 2024 | 17.66 Mn |
| Sep 30, 2024 | 16.94 Mn |
| Jun 30, 2024 | 15.88 Mn |
| Mar 31, 2024 | 17.31 Mn |
| Dec 31, 2023 | 15.71 Mn |
| Sep 30, 2023 | 14.28 Mn |
| Jun 30, 2023 | 12.87 Mn |
| Mar 31, 2023 | 13.93 Mn |
| Dec 31, 2022 | 14.47 Mn |
| Sep 30, 2022 | 12.73 Mn |
| Jun 30, 2022 | 14.43 Mn |
| Mar 31, 2022 | 13.94 Mn |
| Dec 31, 2021 | 12.90 Mn |
| Sep 30, 2021 | 14.49 Mn |